[1] 杨三三,陈安海. 继发性血色病合并亚急性肝衰竭1例报告[J]. 临床肝胆病杂志,2021,37(11):2642-2643.
[2] Stankoski J A, Roth J A, Gillin J S. Chronic active hepatitis and hepatic failure in the setting of idiopathic hemochromatosis[J]. Am J Gastroenterol, 1987, 82(1):61-65.
[3] Forsberg M, Galan M, Kra J. Infectious mononucleosis causing acute liver failure and hemolytic anemia in a patient with underlying hereditary hemochromatosis[J]. Case Rep Oncol,2020,13(3):1232-1238.
[4] Pérez Roldán F, Amigo Echenagusia A, González Carro P, et al. Hemochromatosis presenting as acute liver failure after iron supplementation[J]. N Engl J Med,1998, 339(4):269-270.
[5] Hsu C C, Senussi N H, Fertrin K Y, et al. Iron overload disorders[J]. Hepatol Commun, 2022,6(8):1842-1854.
[6] Bacon B R, Adams P C, Kowdley K V, et al. Diagnosis and management of hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases[J]. Hepatology, 2011, 54(1) :328-343.
[7] Munoz C J,Pires I S,Jani V, et al. Apohemoglobin-haptoglobin complex alleviates iron toxicity in mice with β-thalassemia via scavenging of cell-free hemoglobin and heme[J].Biomed Pharmacother,2022,156:113911.
[8] Fibach E, Rachmilewitz E A . Pathophysiology and treatment of patients with beta-thalassemia-an update[J]. F1000research, 2017, 6:2156.
[9] Taher A T, Cappellini M D . How I manage medical complications of beta-thalassemia in adults[J]. Blood, 2018, 132(17):1781-1791.
[10] 郝坤艳, 汪勇, 于乐成.《2022年欧洲肝病学会血色病临床实践指南》摘译[J]. 临床肝胆病杂志, 2022, 38(9): 1999-2004.
[11] Cabrera E, Crespo G, Vanwagner L B .Diagnosis and management of hereditary hemochromatosis[J].JAMA, 2022, 328(18):1862-1863.
[12] Girelli D, Busti F, Brissot P, et al.Hemochromatosis classification: update and recommendations by the BIOIRON Society[J]. Blood,2022,139(20):3018-3029.
[13] Westphalen A C, Qayyum A, Yeh B M, et al. Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging[J]. Radiology, 2007,242(2):450-455.
[14] Gandon Y, D Olivié, Guyader D, et al. Non-invasive assessment of hepatic iron stores by MRI[J]. Lancet,2004, 363(9406):357-362.
[15] Young O K, Hee K K .Clinical applications of therapeutic phlebotomy[J].Journal of Blood Medicine,2016, 7:139-144.
[16] Deugnier Y, Turlin B, Ropert M, et al. Improvement in liver pathology of patients with β-thalassemia treated with deferasirox for at least 3 years[J]. Gastroenterology, 2011, 141(4):1202-1211.e3.
[17] Aslan N. A case of iron intoxication treated by plasmapheresis ?[J]. Indian J Pediatr,2022, 89(3):315.
[18] Tomlinson B. Ferrous sulphate poisoning treated by exchange Transfusion[J]. Lancet, 1964,2:1015.
[19] 孙梦霞, 程莹, 李飞云,等. 血浆置换联合连续性血液净化技术在再生障碍性贫血患者中的应用[J]. 医学综述, 2022,28(9):1842-1846.
[20] 李列平, 邱发麒, 李雄,等. 双重滤过血浆置换治疗继发性血色病一例[J]. 中华内科杂志, 1999, 38(10):707-707.
[21] Musallam K M, Cappellini M D, Daar S, et al. Serum ferritin level and morbidity risk in transfusion-independent patients with β-thalassemia intermedia: the ORIENT study[J]. Haematologica, 2014, 99(11):218-221. |
